Huihui Zhao

No. 1-1, Zhongfu Road, Jiangsu
Nanjing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Comparison of the real-world efficacy and safety of romiplostim and recombinant human thrombopoietin (rhTPO) in chemotherapy-induced thrombocytopenia.

Comparison of the real-world efficacy and safety of romiplostim and recombinant human thrombopoietin (rhTPO) in chemotherapy-induced thrombocytopenia.

Journal: BMC cancer
Published: October 31, 2025

Venetoclax Plus Blinatumoma as First Line Therapy for Newly Diagnosed Ph-Negative B-Cell Acute Lymphoblastic Leukemia.

Venetoclax Plus Blinatumoma as First Line Therapy for Newly Diagnosed Ph-Negative B-Cell Acute Lymphoblastic Leukemia.

Journal: Blood and lymphatic cancer : targets and therapy
Published: July 29, 2025

Venetoclax with azacitidine and dexamethasone: Non-cytotoxic induction therapy for T-cell leukemia and mixed-phenotype leukemia.

Venetoclax with azacitidine and dexamethasone: Non-cytotoxic induction therapy for T-cell leukemia and mixed-phenotype leukemia.

Journal: Therapeutic advances in hematology
Published: June 27, 2025

hsa_circ_0135681 functions as a novel tumor-suppressive circular RNA regulating Glycolysis and EMT to attenuate cisplatin resistance in non-small cell lung cancer.

hsa_circ_0135681 functions as a novel tumor-suppressive circular RNA regulating Glycolysis and EMT to attenuate cisplatin resistance in non-small cell lung cancer.

Journal: Discover oncology
Published: May 13, 2025

Elevated SGO2 expression in lung adenocarcinoma promotes migration and invasion via MAD2 and correlates with poor prognosis.

Elevated SGO2 expression in lung adenocarcinoma promotes migration and invasion via MAD2 and correlates with poor prognosis.

Journal: Scientific reports
Published: April 05, 2025

Modulation of almonertinib resistance in non-small cell lung cancer by cancer-associated fibroblasts through HK2-mediated glycolysis and SKP2 signaling.

Modulation of almonertinib resistance in non-small cell lung cancer by cancer-associated fibroblasts through HK2-mediated glycolysis and SKP2 signaling.

Journal: Discover oncology
Published: October 13, 2024

Cancer-associated fibroblasts induce almonertinib resistance in non-small cell lung cancer.

Cancer-associated fibroblasts induce almonertinib resistance in non-small cell lung cancer.

Journal: Journal of translational medicine
Published: August 14, 2024

Identifying Factors Affecting the Survival of Patients with HIV-Associated B-Cell Lymphoma Using a Random Survival Forest Model.

Identifying Factors Affecting the Survival of Patients with HIV-Associated B-Cell Lymphoma Using a Random Survival Forest Model.

Journal: Clinical Medicine Insights. Oncology
Published: April 17, 2024

Pan-cancer analysis of prognostic and immunological role of DTYMK in human tumors.

Pan-cancer analysis of prognostic and immunological role of DTYMK in human tumors.

Journal: Frontiers in genetics
Published: July 08, 2022

Prognostic Implication and Immunological Role of PSMD2 in Lung Adenocarcinoma.

Prognostic Implication and Immunological Role of PSMD2 in Lung Adenocarcinoma.

Journal: Frontiers in genetics
Published: March 27, 2022

The clinical features and prognosis of 31 HIV-infected diffuse large B-cell lymphoma cases.

The clinical features and prognosis of 31 HIV-infected diffuse large B-cell lymphoma cases.

Journal: Science progress
Published: June 23, 2021

Metronomic regimen as an effective treatment for aggressive T-LGL leukemia with central nervous system infiltration: clinical experience and review of literature.

Metronomic regimen as an effective treatment for aggressive T-LGL leukemia with central nervous system infiltration: clinical experience and review of literature.

Journal: Oncotarget
Published: June 03, 2016
Showing 1-12 of 12

Last Updated: 09/26/2026